Table 5. Severity of neutropenia among patients.

Chemotherapy cycle	Neutropenia (ANC) n (%)			Total n (%)
	Mild (>1,000–1,500 cells/μL)	Moderate (500–1,000 cells/μL)	Severe (<500 cells/μL)
Post cycle 1 (n = 113)	9 (8.0)	6 (5.3)	1 (0.9)	16 (13.3)
Post cycle 2 (n = 112)	10 (8.9)	3 (2.7)	0 (0.0)	13 (11.6)
Post cycle 3 (n = 102)	5 (4.9)	6 (5.9)	2 (1.9)	13 (12.7)
Post cycle 4 (n = 75)	3 (4.0)	2 (2.7)	3 (4.0)	8 (10.7)
Post cycle 5 (n = 59)	4 (6.8)	0 (0.0)	1 (1.7)	5 (8.5)
Post cycle 6 (n = 41)	2 (4.9)	0 (0.0)	0 (0.0)	2 (4.9)
Total (n = 502)	33 (6.6)	17 (3.4)	7 (1.4)	57 (11.4)